Detalhe da pesquisa
1.
Cellular therapy in lymphoma.
Hematol Oncol
; 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382086
2.
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma.
Cancer Immunol Immunother
; 71(9): 2277-2286, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098345
3.
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Cancer Immunol Immunother
; 71(6): 1531-1543, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661709
4.
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Am J Hematol
; 97(9): 1159-1169, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726449
5.
Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients.
Blood
; 140(2): 156-160, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35472242
6.
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma.
Hematol Oncol
; 37(3): 253-260, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30983008
7.
WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients.
Ann Hematol
; 94(5): 761-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519475
8.
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations.
Discov Oncol
; 14(1): 132, 2023 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466782
9.
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.
J Clin Oncol
; 41(12): 2238-2247, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36548927
10.
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.
Leuk Lymphoma
; 64(11): 1782-1791, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477443
11.
Case report: cytomegalovirus-induced thrombosis in an immunocompetent patient.
J Med Virol
; 84(1): 116-8, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22095539
13.
Low-dose 'boom-boom' radiotherapy for ocular lymphoma arising from IgG4-related ophthalmic disease: Case report and literature review.
Eur J Ophthalmol
; 32(6): NP78-NP84, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030509
14.
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
Cancer Rep (Hoboken)
; 5(9): e1552, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35481622
15.
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.
Onco Targets Ther
; 14: 3921-3928, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34234460
16.
Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215687
17.
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia.
Int J Hematol
; 114(3): 355-362, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302593
18.
Rapid production of clinical-grade SARS-CoV-2 specific T cells.
Adv Cell Gene Ther
; 3(4): e101, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32838213
19.
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.
Clin Cancer Res
; 26(17): 4494-4502, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522887
20.
Plasma Factors for the Differentiation of Hodgkin's Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission.
J Hematol
; 8(2): 47-54, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32300443